{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:35:38Z","timestamp":1790674538992,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JSPS-RFTF 97I 00201"],"award-info":[{"award-number":["JSPS-RFTF 97I 00201"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017391","name":"Japan Private School Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.metabol.2003.11.021","type":"journal-article","created":{"date-parts":[[2004,3,20]],"date-time":"2004-03-20T12:09:07Z","timestamp":1079784547000},"page":"488-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Pioglitazone improves insulin secretory capacity and prevents the loss of \u03b2-cell mass in obese diabetic db\/db mice: possible protection of \u03b2 cells from oxidative stress"],"prefix":"10.1016","volume":"53","author":[{"given":"Hitoshi","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachihiko","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nakamichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Katahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nagamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2003.11.021_BIB1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","article-title":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus","volume":"340","author":"Martin","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2003.11.021_BIB2","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfuncton as precursors of non-insulin-dependent diabetes mellitus","volume":"329","author":"Lillioja","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2003.11.021_BIB3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199603213341207","article-title":"Non-insulin-dependent diabetes mellitus","volume":"334","author":"Polonsky","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2003.11.021_BIB4","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor \u03b3","volume":"270","author":"Lehmann","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2003.11.021_BIB5","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1210\/endo.137.10.8828476","article-title":"Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor \u03b3","volume":"137","author":"Berger","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2003.11.021_BIB6","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1073\/pnas.96.20.11513","article-title":"Troglitazone prevents mitochondrial alterations, beta cell destruction and diabetes in obese prediabetic rats","volume":"96","author":"Higa","year":"1999","journal-title":"Proc Natl Sci USA"},{"key":"10.1016\/j.metabol.2003.11.021_BIB7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2337\/diabetes.50.5.1021","article-title":"\u03b2 cell mass dynamics in Zucker diabetic fatty rats","volume":"50","author":"Finegood","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.271.5251.994","article-title":"Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor","volume":"271","author":"Chua","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.metabol.2003.11.021_BIB9","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/endo-122-6-2436","article-title":"The number of 1,25-dihydroxyvitamin D3 receptors is decreased in both intestine and kidney of genetically diabetic db\/db mice","volume":"122","author":"Ishida","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2003.11.021_BIB10","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.95.15.8898","article-title":"Role of peroxisome proliferator-activated receptor \u03b1 in disease of pancreatic \u03b2 cells","volume":"95","author":"Zhou","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2003.11.021_BIB11","series-title":"Diabetes Mellitus. A Fundamental and Clinical Text","first-page":"132","article-title":"Lipotoxicity","author":"Unger","year":"2000"},{"key":"10.1016\/j.metabol.2003.11.021_BIB12","first-page":"263","article-title":"Effect of pioglitazone on glucose and lipid metabolism in Wistar fatty rats","volume":"40","author":"Sugiyama","year":"1990","journal-title":"Arzneimforsch Drug Res"},{"key":"10.1016\/j.metabol.2003.11.021_BIB13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/bbrc.1996.0912","article-title":"Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa\/fa) rats","volume":"223","author":"Hayakawa","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2003.11.021_BIB14","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1073\/pnas.96.19.10857","article-title":"Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants","volume":"96","author":"Tanaka","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2003.11.021_BIB15","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/diabetes.48.12.2398","article-title":"Beneficial effects of antioxidants in diabetes","volume":"48","author":"Kaneto","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(24)39254-7","article-title":"Pancreatic \u03b2-cell KATP channel activity and membrane-binding studies with nateglinide","volume":"293","author":"Hu","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2003.11.021_BIB17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2003.11.021_BIB18","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2337\/diabetes.48.12.2367","article-title":"Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic \u03b2-cells is involved in impaired insulin secretion from diabetic GK rat islets","volume":"48","author":"Nagamatsu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1210\/endo.139.3.5771","article-title":"The novel insulinotropic mechanism of pimobendan","volume":"139","author":"Fujimoto","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2003.11.021_BIB20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0026-0495(88)90064-9","article-title":"Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model","volume":"37","author":"Tsuji","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2003.11.021_BIB21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1084\/jem.176.4.1233","article-title":"Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice","volume":"176","author":"Than","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2003.11.021_BIB22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/diacare.15.3.318","article-title":"Pathogenesis of NIDDM","volume":"15","author":"DeFronzo","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2003.11.021_BIB23","first-page":"415","article-title":"Glucose toxicity","volume":"13","author":"Yki-Jarvinen","year":"1992","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.metabol.2003.11.021_BIB24","doi-asserted-by":"crossref","first-page":"33501","DOI":"10.1074\/jbc.273.50.33501","article-title":"Glucose and tolbutamide induce apoptosis in pancreatic \u03b2-cells","volume":"273","author":"Efanova","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2003.11.021_BIB25","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1073\/pnas.97.6.2820","article-title":"Glucose stimulates protein modification by O-linked GlcNAc in pancreatic \u03b2 cells","volume":"97","author":"Liu","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2003.11.021_BIB26","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1074\/jbc.273.6.3547","article-title":"Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats","volume":"273","author":"Shimabukuro","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2003.11.021_BIB27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1006\/bbrc.2001.4608","article-title":"Acute inhibition of proinsulin biosynthesis at the translational level by palmitic acid","volume":"282","author":"Katahira","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2003.11.021_BIB28","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1073\/pnas.95.5.2498","article-title":"Fatty acid-induced \u03b2 cell apoptosis","volume":"95","author":"Shimabukuro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2003.11.021_BIB29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/endo.143.2.8623","article-title":"Minireview","volume":"143","author":"Poitout","year":"2002","journal-title":"Endocrionology"},{"key":"10.1016\/j.metabol.2003.11.021_BIB30","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2337\/diabetes.50.11.2481","article-title":"Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycenol content and decreased insulin gene mRNA levels in Zucker diabetic fatty rats","volume":"50","author":"Harmon","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diab.45.6.711","article-title":"Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet \u03b2-cells","volume":"45","author":"Harbeck","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB32","first-page":"1243","article-title":"Insulin receptor signaling in the \u03b2-cell influences insulin gene expression and insulin content","volume":"47","author":"Xu","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB33","series-title":"Diabetes Mellitus. A Fundamental and Clinical Text","first-page":"199","article-title":"Insulin receptor substrate proteins mediate common signaling pathways for insulin action and \u03b2-cell function","author":"White","year":"2000"},{"key":"10.1016\/j.metabol.2003.11.021_BIB34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(00)80546-2","article-title":"Tissue-specific knockout of the insulin receptor in pancreatic \u03b2 cells creates an insulin secretory defect similar to that in type 2 diabetes","volume":"96","author":"Kulkarni","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2003.11.021_BIB35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/diabetes.51.3.676","article-title":"Peroxisomal proliferator-activated receptor-\u03b3 upregulates glucokinase gene expression in \u03b2 cells","volume":"51","author":"Kim","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB36","doi-asserted-by":"crossref","first-page":"18702","DOI":"10.1074\/jbc.274.26.18702","article-title":"Tumor necrosis factor \u03b1-induced pancreatic \u03b2-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-\u039412,14-prostaglandin J2 and aminoguanidine","volume":"274","author":"Kwon","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2003.11.021_BIB37","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","article-title":"PPAR\u03b3 ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein","volume":"50","author":"Maeda","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.11.021_BIB38","first-page":"E1125","article-title":"Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats","volume":"284","author":"Iida","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2003.11.021_BIB39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1023\/A:1022138519281","article-title":"Improvement of aortic wall distensibility and reduction of oxidative stress by pioglitazone in pre-diabetic stage of Otsuka Long-Evans Tokushima fatty rats","volume":"16","author":"Tsuji","year":"2002","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049503005523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049503005523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:00:00Z","timestamp":1758420000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049503005523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0026049503005523"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2003.11.021","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioglitazone improves insulin secretory capacity and prevents the loss of \u03b2-cell mass in obese diabetic db\/db mice: possible protection of \u03b2 cells from oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2003.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}